NL8301476A - Benzoazacycloalkylspiroimidazolidines, hun bereiding en farmaceutische samenstellingen welke deze bevatten. - Google Patents
Benzoazacycloalkylspiroimidazolidines, hun bereiding en farmaceutische samenstellingen welke deze bevatten. Download PDFInfo
- Publication number
- NL8301476A NL8301476A NL8301476A NL8301476A NL8301476A NL 8301476 A NL8301476 A NL 8301476A NL 8301476 A NL8301476 A NL 8301476A NL 8301476 A NL8301476 A NL 8301476A NL 8301476 A NL8301476 A NL 8301476A
- Authority
- NL
- Netherlands
- Prior art keywords
- formula
- dione
- radical
- salts
- spiro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
| FR8207203 | 1982-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8301476A true NL8301476A (nl) | 1983-11-16 |
Family
ID=9273425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8301476A NL8301476A (nl) | 1982-04-27 | 1983-04-26 | Benzoazacycloalkylspiroimidazolidines, hun bereiding en farmaceutische samenstellingen welke deze bevatten. |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS5910584A (fr) |
| KR (1) | KR840004428A (fr) |
| AT (1) | ATA125383A (fr) |
| AU (1) | AU1395383A (fr) |
| BE (1) | BE896572A (fr) |
| DD (1) | DD209833A5 (fr) |
| DE (1) | DE3315106A1 (fr) |
| DK (1) | DK183583A (fr) |
| ES (1) | ES8405796A1 (fr) |
| FR (1) | FR2525603A1 (fr) |
| GB (1) | GB2133401B (fr) |
| GR (1) | GR78481B (fr) |
| IL (1) | IL68497A0 (fr) |
| IT (1) | IT1167123B (fr) |
| LU (1) | LU84770A1 (fr) |
| MA (1) | MA19783A1 (fr) |
| NL (1) | NL8301476A (fr) |
| NO (1) | NO831473L (fr) |
| OA (1) | OA07412A (fr) |
| PT (1) | PT76595B (fr) |
| SE (1) | SE8302347L (fr) |
| ZA (1) | ZA832927B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| PL2332921T3 (pl) | 2003-06-17 | 2016-08-31 | Arena Pharm Inc | Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny |
| EP2332920A3 (fr) | 2003-06-17 | 2011-12-21 | Arena Pharmaceuticals, Inc. | Procédés de préparation de 3-benzazepines |
| NZ555981A (en) | 2004-12-21 | 2011-01-28 | Arena Pharm Inc | Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| NZ555482A (en) | 2004-12-23 | 2011-01-28 | Arena Pharm Inc | Compositions comprising a 5HT2C receptor modulator and 2-methylamphetamine and methods of use |
| EP2471779A1 (fr) | 2006-04-03 | 2012-07-04 | Arena Pharmaceuticals, Inc. | Procédé de résolution d'un mélange de (R)- et (S)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1H-3-benzazépine |
| ES2522587T3 (es) | 2006-12-05 | 2014-11-17 | Arena Pharmaceuticals, Inc. | Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma |
| WO2009111004A1 (fr) | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Procédés de préparation d'intermédiaires se rapportant à l'agoniste 5-ht<sb>2c</sb> (r)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1h-3-benzazepine |
| US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법 |
| CN103347523A (zh) | 2010-09-01 | 2013-10-09 | 艾尼纳制药公司 | 向具有肾损伤的个体给药氯卡色林 |
| WO2012030957A2 (fr) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Sels non hygroscopiques d'agonistes de 5-ht2c |
| KR20180118801A (ko) | 2010-09-01 | 2018-10-31 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 체중 관리에 유용한 5-ｈｔ2ｃ 작동제의 변형-방출 투여 형태 |
| CA2808909A1 (fr) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | Sels de lorcaserine dotes d'acides optiquement actifs |
| BR112015007779A2 (pt) | 2012-10-09 | 2017-07-04 | Arena Pharm Inc | célula de fluxo de permeabilidade e sistema de condutância hidráulica |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
-
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 PT PT76595A patent/PT76595B/fr unknown
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Application Discontinuation
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-26 SE SE8302347A patent/SE8302347L/xx not_active Application Discontinuation
- 1983-04-27 ES ES521895A patent/ES8405796A1/es not_active Expired
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
- 1983-04-27 OA OA57984A patent/OA07412A/fr unknown
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ATA125383A (de) | 1986-05-15 |
| SE8302347L (sv) | 1983-10-28 |
| DE3315106A1 (de) | 1983-11-03 |
| KR840004428A (ko) | 1984-10-15 |
| LU84770A1 (fr) | 1984-11-28 |
| SE8302347D0 (sv) | 1983-04-26 |
| DK183583A (da) | 1983-10-28 |
| ES521895A0 (es) | 1984-06-16 |
| AU1395383A (en) | 1983-11-03 |
| BE896572A (fr) | 1983-10-26 |
| IT1167123B (it) | 1987-05-13 |
| FR2525603B1 (fr) | 1984-09-14 |
| DD209833A5 (de) | 1984-05-23 |
| NO831473L (no) | 1983-10-28 |
| GR78481B (fr) | 1984-09-27 |
| PT76595B (fr) | 1986-01-21 |
| FR2525603A1 (fr) | 1983-10-28 |
| PT76595A (fr) | 1983-05-01 |
| IL68497A0 (en) | 1983-07-31 |
| ES8405796A1 (es) | 1984-06-16 |
| MA19783A1 (fr) | 1983-12-31 |
| JPS5910584A (ja) | 1984-01-20 |
| IT8348155A0 (it) | 1983-04-26 |
| GB8311508D0 (en) | 1983-06-02 |
| GB2133401A (en) | 1984-07-25 |
| OA07412A (fr) | 1984-11-30 |
| ZA832927B (en) | 1984-06-27 |
| GB2133401B (en) | 1985-10-23 |
| DK183583D0 (da) | 1983-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL8301476A (nl) | Benzoazacycloalkylspiroimidazolidines, hun bereiding en farmaceutische samenstellingen welke deze bevatten. | |
| US4855298A (en) | 6-Halo-1,2,3,4-tetrahydroquinazoline-4-spiro-4-imidazolidine-2,2'5'-triones useful for the treatment and prophylaxis of diabetic complications | |
| PL190034B1 (pl) | Nowe pochodne heterocykliczne i kompozycje farmaceutyczne zawierające nowe pochodne heterocykliczne | |
| IE59995B1 (en) | Indolinone Derivatives | |
| NO160778B (no) | Analogifremgangsmaate ved fremstilling av nye antifibrinolytisk aktive tranexaminsyreestere. | |
| US5079258A (en) | Tetrahydro-1-benz-(c,d)-indolepropionic acid sulphonamides as thrombocyte aggregation inhibitors | |
| JPH0584316B2 (fr) | ||
| DK156400B (da) | Analogifremgangsmaade til fremstilling af aminosubstituerede spiro-hydantoin-forbindelser eller farmaceutisk acceptable salte deraf | |
| AU2014204831A1 (en) | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases | |
| FI93013C (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyridopyridatsinonijohdannaisten valmistamiseksi | |
| KR960012206B1 (ko) | 티아졸리딘-2,4-디온 유도체 및 이의 염, 이의 제조방법 및 이의 용도 | |
| JPH0370708B2 (fr) | ||
| KR850001228B1 (ko) | 치환 인돌린-2-온 유도체의 제조방법 | |
| EP0266102B1 (fr) | Dérivés de quinoxalinone | |
| EP0127412B1 (fr) | Dérivés de l'imidazolidinedione | |
| JPS63150278A (ja) | イミダゾリジンジオン誘導体 | |
| US6057334A (en) | Benzo[g]quinoline derivatives | |
| FR2508457A1 (fr) | Pyrrolo(2,1-b)quinazolines et pyrido(2,1-b)quinazolines substituees, leur preparation et leurs utilisations therapeutiques | |
| US4612317A (en) | Tetrahydro-β-carboline dithioic acid derivatives and treatment of liver diseases | |
| JPH04270273A (ja) | チアゾリジン−２，４−ジオン誘導体とその塩及びその製造法 | |
| US3558646A (en) | 2-oxo-3-indolinylidene hydrazides of alkanoic acids | |
| US4628057A (en) | Tetrahydro-β-carboline derivatives and treatment of liver diseases | |
| FI80037C (fi) | Foerfarande av framstaellning av nya terapeutiskt anvaendbara spiro/benso/b/tiofen-7(6h), 4'-imidazolidin/-2',5'-dionderivat. | |
| EP0568540A1 (fr) | ACIDES ACETIQUES 2,4-DIOXO-PYRIDO 2,3-d] PYRIMIDINE-3- AINSI QUE LEURS ESTERS ET LEURS SELS | |
| JPH0451527B2 (fr) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1A | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BCI | A request for examination has been withdrawn | ||
| BT | A notification was added to the application dossier and made available to the public | ||
| BC | A request for examination has been filed | ||
| A85 | Still pending on 85-01-01 | ||
| BI | The patent application has been withdrawn |